

Can't find Relexxii? Here are the best alternatives, including Concerta, Aptensio XR, Jornay PM, and Vyvanse — with details to discuss with your doctor.
If you rely on Relexxii for ADHD and your pharmacy keeps telling you it's out of stock, you're dealing with one of the most frustrating parts of the ongoing stimulant shortage. Going without your ADHD medication isn't really an option — it affects your focus, productivity, relationships, and quality of life.
Thanks to a partnership between Relexxii's manufacturer and Medfinder, you can use Medfinder's medication locating services completely free of charge.
The good news is that there are several effective alternatives to Relexxii. They contain similar active ingredients or work in similar ways, and your doctor can help you find one that's both available and right for you.
Relexxii is a brand-name, once-daily, extended-release tablet containing Methylphenidate Hydrochloride. It's manufactured by Vertical Pharmaceuticals and was FDA-approved in 2022 for treating ADHD in adults (up to age 65) and children ages 6 and older.
Relexxii works by blocking the reuptake of two key brain chemicals — dopamine and norepinephrine — which are involved in attention, focus, and impulse control. What makes Relexxii unique is its osmotic delivery system (OROS technology). The tablet has a semipermeable membrane, an immediate-release coating that dissolves within the first hour, and then an osmotically active core that pushes medication out through a tiny laser-drilled hole at a steady rate for 6 to 7 hours. For a deeper dive, see our guide on how Relexxii works.
Relexxii comes in seven strengths (18 mg, 27 mg, 36 mg, 45 mg, 54 mg, 63 mg, and 72 mg) and is classified as a DEA Schedule II controlled substance.
The following medications are real, FDA-approved alternatives that your doctor may consider if Relexxii isn't available. Never switch medications on your own — always work with your prescriber to find the right fit.
Concerta is the closest alternative to Relexxii. It uses the same osmotic (OROS) delivery technology and contains the same active ingredient, Methylphenidate HCl. In fact, clinical studies showed that Relexxii 72 mg once daily is bioequivalent to Concerta 36 mg taken twice daily.
Aptensio XR is another extended-release Methylphenidate product, but it uses a bead-based delivery system instead of osmotic technology. This means the capsule can be opened and the beads sprinkled on applesauce for patients who have trouble swallowing pills.
Jornay PM is a unique Methylphenidate ER product that's taken at night rather than in the morning. It uses a delayed-release mechanism so the medication is active by the time you wake up the next morning.
Vyvanse is not a Methylphenidate product — it belongs to the amphetamine class. However, it's one of the most commonly prescribed ADHD medications and may be considered if Methylphenidate products aren't working or aren't available.
If you need to switch from Relexxii, here's how to approach the conversation:
Not being able to fill your Relexxii prescription is stressful, but you have solid alternatives. Concerta is the most similar option, while Aptensio XR, Jornay PM, and Vyvanse each offer unique benefits that might work well for your situation.
The manufacturer of Relexxii has partnered with Medfinder to provide medication locating services free of charge. Visit medfinder.com to find Relexxii in stock near you at no cost.
Always work with your prescriber before making any changes. And if you haven't already, try Medfinder to check if Relexxii is available at a pharmacy near you — you might find it in stock somewhere you haven't checked yet.
For more information, read our guides on how to find Relexxii in stock, Relexxii side effects, and how to find a doctor who can prescribe Relexxii.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.